Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study
Metadatos
Mostrar el registro completo del ítemAutor
Torres-Martos, Álvaro; Anguita-Ruiz, Augusto; Bustos-Aibar, Mireia; Ramírez-Mena, Alberto; Arteaga, María; Bueno, Gloria; Leis, Rosaura; Aguilera García, Concepción María; Alcalá Fernández, Rafael; Alcalá-Fdez, JesúsMateria
Pediatric obesity Insulin resistance Epigenomics Multiomics Machine Learning Explainable Artificial Intelligence
Fecha
2024Referencia bibliográfica
Torres-Martos, Á., Anguita-Ruiz, A., Bustos-Aibar, M., Ramírez-Mena, A., Arteaga, M., Bueno, G., Leis, R., Aguilera, C. M., Alcalá, R., & Alcalá-Fdez, J. (2024). Multiomics and eXplainable artificial intelligence for decision support in insulin resistance early diagnosis: A pediatric population-based longitudinal study. Artificial intelligence in medicine, 156, 102962. https://doi.org/10.1016/j.artmed.2024.102962
Patrocinador
This research was supported by the Instituto de Salud Carlos III cofunded by the European Union and ERDF A way of making Europe (grant numbers PI20/00711, PI20/00563, PI20/00924, P20/00988, PI23/00028, PI23/00129, PI23/01032, PI23/00165 and also PI23/00191), and by the European Union through the Horizon Europe Framework Programme (eprObes project, grant number GA 101080219). The authors also acknowledge Instituto de Salud Carlos III for personal funding of A.A.R, A.T.M and M.B.A.: i-PFIS and PFIS contracts: IIS doctorates - company in health sciences and technologies of the Strategic Health Action (IFI17/00048, IFI22/00013 and FI23/00042). We also thank the support from the grant FJC2021- 046952-I by Ministerio de Ciencia, Innovación y Universidades y Agencia Estatal de Investigación.. Funding for open access charge: Universidad de Granada/CBUA.Resumen
Pediatric obesity can drastically heighten the risk of cardiometabolic alterations later in life, with insulin
resistance standing as the cornerstone linking adiposity to the increased cardiovascular risk. Puberty has been
pointed out as a critical stage after which obesity-associated insulin resistance is more difficult to revert. Timely
prediction of insulin resistance in pediatric obesity is therefore vital for mitigating the risk of its associated
comorbidities. The construction of effective and robust predictive systems for a complex health outcome like
insulin resistance during the early stages of life demands the adoption of longitudinal designs for more causal
inferences, and the integration of factors of varying nature involved in its onset. In this work, we propose
an eXplainable Artificial Intelligence-based decision support pipeline for early diagnosis of insulin resistance
in a longitudinal cohort of 90 children. For that, we leverage multi-omics (genomics and epigenomics) and
clinical data from the pre-pubertal stage. Different data layers combinations, pre-processing techniques (missing values, feature selection, class imbalance, etc.), algorithms, training procedures were considered following good practices for Machine Learning. SHapley Additive exPlanations were provided for specialists to understand both the decision-making mechanisms of the system and the impact of the features on each automatic decision, an essential issue in high-risk areas such as this one where system decisions may affect people’s lives. The system showed a relevant predictive ability (AUC and G-mean of 0.92). A deep exploration, both at the global and the local level, revealed promising biomarkers of insulin resistance in our population, highlighting classical markers, such as Body Mass Index z-score or leptin/adiponectin ratio, and novel ones such as methylation patterns of relevant genes, such as HDAC4, PTPRN2, MATN2, RASGRF1 and EBF1. Our findings highlight the importance of integrating multi-omics data and following eXplainable Artificial Intelligence trends when building decision support systems